AR207355A1 - Un procedimiento para la preparacion de derivados del acido 7-(-(4-hidroxi-4-alquil-1-alquenil)ciclopentano)-1-heptanoico - Google Patents

Un procedimiento para la preparacion de derivados del acido 7-(-(4-hidroxi-4-alquil-1-alquenil)ciclopentano)-1-heptanoico

Info

Publication number
AR207355A1
AR207355A1 AR258109A AR25810975A AR207355A1 AR 207355 A1 AR207355 A1 AR 207355A1 AR 258109 A AR258109 A AR 258109A AR 25810975 A AR25810975 A AR 25810975A AR 207355 A1 AR207355 A1 AR 207355A1
Authority
AR
Argentina
Prior art keywords
cyclopentan
alkenyl
hydroxy
derivatives
alkyl
Prior art date
Application number
AR258109A
Other languages
English (en)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of AR207355A1 publication Critical patent/AR207355A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
AR258109A 1974-03-26 1975-01-01 Un procedimiento para la preparacion de derivados del acido 7-(-(4-hidroxi-4-alquil-1-alquenil)ciclopentano)-1-heptanoico AR207355A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/454,913 US3965143A (en) 1974-03-26 1974-03-26 16-Oxygenated prostanoic acid derivatives

Publications (1)

Publication Number Publication Date
AR207355A1 true AR207355A1 (es) 1976-09-30

Family

ID=23806587

Family Applications (1)

Application Number Title Priority Date Filing Date
AR258109A AR207355A1 (es) 1974-03-26 1975-01-01 Un procedimiento para la preparacion de derivados del acido 7-(-(4-hidroxi-4-alquil-1-alquenil)ciclopentano)-1-heptanoico

Country Status (25)

Country Link
US (1) US3965143A (es)
JP (1) JPS5855142B2 (es)
AR (1) AR207355A1 (es)
AT (1) AT351684B (es)
BE (1) BE827127A (es)
CA (1) CA1040197A (es)
CH (1) CH613443A5 (es)
DE (1) DE2513212C2 (es)
DK (1) DK128075A (es)
EG (1) EG12063A (es)
ES (1) ES436043A1 (es)
FI (1) FI63747C (es)
FR (1) FR2274289A1 (es)
GB (1) GB1492426A (es)
HU (1) HU174973B (es)
IE (1) IE41328B1 (es)
IL (1) IL46919A (es)
NL (2) NL183294B (es)
NO (1) NO146200C (es)
OA (1) OA04910A (es)
PH (1) PH16276A (es)
PL (1) PL100838B1 (es)
SE (1) SE420199B (es)
YU (1) YU39735B (es)
ZA (1) ZA751391B (es)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113723A (en) * 1972-07-13 1978-09-12 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
US4293704A (en) * 1975-09-25 1981-10-06 American Cyanamid Company Novel 2-substituted-3,4-epoxycyclopentan-1-ones, 2-substituted-3,4-epoxycyclopentan-1-ols, and various 2-substituted-cyclopentenones
US4107441A (en) * 1973-06-15 1978-08-15 American Cyanamid Company Novel 16 hydroxy 15-deoxy-5-cis-prostenoic acids and esters
US4060691A (en) * 1974-03-26 1977-11-29 G. D. Searle & Co. 7-{3-Hydroxy-2-[4-hydroxy-4-(lower alkyl)-trans-1-octen-1-yl]-5-oxocyclopent-1-yl}heptanoic acids and esters
US4328358A (en) * 1976-07-19 1982-05-04 American Cyanamid Company 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners
US4190596A (en) * 1976-07-19 1980-02-26 American Cyanamid Company Various 15-deoxy-16-hydroxy-16-ethynyl and 16-ethynylsubstituted prostaglandins
US4730065A (en) * 1976-07-19 1988-03-08 American Cyanamid Company 15-deoxy-16-hydroxy-16-substituted prostanoic acids and congeners
US4191699A (en) * 1976-07-19 1980-03-04 American Cyanamid Company Various- 15-deoxy-16-hydroxy-16-ethynyl and 16-ethynylsubstituted prostaglandins
US4429148A (en) 1976-07-19 1984-01-31 American Cyanamid Company 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners
US4061670A (en) * 1976-07-19 1977-12-06 American Cyanamid Company 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic acids and congeners
US4192950A (en) * 1976-07-19 1980-03-11 American Cyanamid Company 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners
AU3437478A (en) * 1977-03-30 1979-09-27 American Cyanamid Co Prostanoic acids and congeners
US4281153A (en) * 1977-08-01 1981-07-28 American Cyanamid 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners
GB2006186A (en) * 1977-08-29 1979-05-02 American Cyanamid Co 15-Deoxy-16-substituted prostanoic acids
GB2009162A (en) * 1977-12-05 1979-06-13 American Cyanamid Co Prostanoic acids and congeners
AU529836B2 (en) * 1977-12-05 1983-06-23 American Cyanamid Company Prostaglandin analog
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins
US4742080A (en) * 1978-02-23 1988-05-03 Miles Laboratories, Inc. Therapeutic method for producing bronchodilation by administration of 15-deoxy-16-hydroxy prostaglandin esters
US4833157A (en) * 1978-02-23 1989-05-23 Miles Inc. Methods of inhibitng gastric secretion with prostaglandin derivatives
US4239899A (en) * 1979-09-13 1980-12-16 American Cyanamid Company Various 15-deoxy-16-hydroxy-16-ethynyl and 16-ethynylsubstituted prostaglandins
US4322543A (en) * 1979-11-28 1982-03-30 G. D. Searle & Co. 4,5-Unsaturated prostanoic acid derivatives
US4271314A (en) * 1979-11-28 1981-06-02 G. D. Searle & Co. 4,5-Unsaturated prostanoic acid derivatives
US4291175A (en) * 1980-04-03 1981-09-22 American Cyanamid Company 1-Hydroxymethyl-11-deoxy-15-hydroxy-prosten-1-ol-derivatives
US4289910A (en) * 1980-04-03 1981-09-15 American Cyanamid Company 1-Hydroxymethyl-prosten-1-ol derivatives
US4310700A (en) * 1980-04-03 1982-01-12 American Cyanamid Company 1-Hydroxylmethyl-11-deoxy-16-hydroxy-prosten-1-ol-derivatives
US4288630A (en) * 1980-04-03 1981-09-08 American Cyanamid Company 1-Hydroxymethyl-11,15-dihydroxy-prosten-1-ol-derivatives
US4288629A (en) * 1980-04-03 1981-09-08 American Cyanamid Company 1-Hydroxymethyl-11-deoxy-15-hydroxy-prosten-1-ol-derivatives
US4288632A (en) * 1980-04-03 1981-09-08 American Cyanamid Company 1-Hydroxymethyl-11,16-dihydroxy-prosten-1-ol derivatives
US4288633A (en) * 1980-04-03 1981-09-08 American Cyanamid Company 1-Hydroxymethyl-11-deoxy-16-hydroxy-prosten-1-ol-derivatives
US4291174A (en) * 1980-04-03 1981-09-22 American Cyanamid Company 1-Hydroxymethyl-15-hydroxy-prosten-1-ol derivatives
US4301146A (en) * 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives
US4399290A (en) * 1980-09-22 1983-08-16 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl)heptanoates
US4459310A (en) * 1983-06-27 1984-07-10 G.D. Searle & Co. Method for cholesterol lowering
US4499296A (en) * 1983-11-14 1985-02-12 G. D. Searle & Co. Omega cycloalkyl prostaglandins
US4754059A (en) * 1984-11-07 1988-06-28 G. D. Searle & Co. Omega cycloalkyl prostaglandins
US4683328A (en) * 1985-11-25 1987-07-28 G. D. Searle & Co. Tetraenyl prostaglandins
US4820728A (en) * 1985-11-25 1989-04-11 G. D. Searle & Co. Tetraenyl prostaglandins
US4847293A (en) * 1985-11-25 1989-07-11 G. D. Searle & Co. Tetraenyl prostaglandins
US5011958A (en) * 1987-06-08 1991-04-30 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US4785124A (en) * 1987-06-08 1988-11-15 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US4777275A (en) * 1987-06-09 1988-10-11 G. D. Searle & Co. Process of preparing higher order cuprate complexes
US5252763A (en) * 1990-04-17 1993-10-12 G. D. Searle & Co. Process for preparing prostaglandin analogs
US5055604A (en) * 1990-04-17 1991-10-08 G. D. Searle & Co. Process for preparing prostaglandin analogs using organozirconium compounds
AU7793791A (en) * 1990-05-03 1991-11-27 G.D. Searle & Co. Pharmaceutical composition for use in treating pain
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5218139A (en) * 1990-12-27 1993-06-08 G. D. Searle & Co. Method for inhibiting IgE production
US5157052A (en) * 1990-12-27 1992-10-20 Monsanto Company Method for inhibiting ige production
US5324746A (en) * 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
US5684177A (en) * 1996-05-17 1997-11-04 Torcan Chemical Ltd. Misoprostol
EP0807634B1 (en) * 1996-05-17 2003-04-09 TORCAN CHEMICAL Ltd Misoprostol, process for its preparation using an organometallic cuprate complex
WO1997045114A1 (en) * 1996-05-30 1997-12-04 Lysis Corporation The treatment of vascular disease with prostaglandins via a sustained-release dermal patch
US5994399A (en) * 1997-03-27 1999-11-30 Mckee; Rex N. Method of regenerating collagen-containing tissues with misoprostol
US6030959A (en) * 1997-04-04 2000-02-29 Monsanto Company Gastro-specific prodrugs
CA2295595A1 (en) 1997-07-09 1999-01-21 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US5889051A (en) * 1997-07-15 1999-03-30 Development Center For Biotechnology Stabilization of prostaglandin drug
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
TW200413000A (en) 2002-10-10 2004-08-01 Ono Pharmaceutical Co Intrinsic repair factor producing accelerator
WO2004032964A1 (ja) * 2002-10-10 2004-04-22 Ono Pharmaceutical Co., Ltd. アレルギー性疾患治療剤
EP2422814A1 (en) 2003-07-25 2012-02-29 Ono Pharmaceutical Co., Ltd. Remedy for cartilage-related diseases
US7241746B2 (en) * 2003-08-06 2007-07-10 Regena Therapeutics, Lc Method and composition for treating periodontal disease
US8735394B2 (en) 2005-02-18 2014-05-27 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
WO2007146795A2 (en) * 2006-06-12 2007-12-21 Ironwood Pharmaceuticals, Inc. Pharmaceutical formulation for parenteral administration
US20150272874A1 (en) 2012-10-29 2015-10-01 Cardio Incorporated Pulmonary disease-specific therapeutic agent
JP6449166B2 (ja) 2013-10-15 2019-01-09 小野薬品工業株式会社 薬剤溶出性ステントグラフト
HU231185B1 (hu) 2017-07-11 2021-07-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Eljárás Misoprostol előállítására és tisztítására
CN108753898A (zh) * 2018-04-09 2018-11-06 深圳市祥根生物科技有限公司 一种米索前列醇酸的制备方法及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812172A (en) * 1970-05-04 1974-05-21 Upjohn Co 15-methyl and 15-ethyl dihydro-pge1
ZA72646B (en) * 1971-03-11 1973-09-26 Upjohn Co Prostaglandin analogs
GB1444971A (en) * 1972-07-24 1976-08-04 American Cyanamid Co Derivatives of prostanoic acid

Also Published As

Publication number Publication date
FI63747B (fi) 1983-04-29
IL46919A0 (en) 1975-05-22
AU7947175A (en) 1976-09-30
PL100838B1 (pl) 1978-11-30
NL930058I1 (nl) 1993-09-01
US3965143A (en) 1976-06-22
OA04910A (fr) 1980-10-31
IL46919A (en) 1979-12-30
FI750899A (es) 1975-09-27
CH613443A5 (es) 1979-09-28
NO146200B (no) 1982-05-10
NO146200C (no) 1982-08-18
BE827127A (fr) 1975-09-25
JPS50135059A (es) 1975-10-25
NL183294B (nl) 1988-04-18
ES436043A1 (es) 1977-01-16
EG12063A (en) 1978-09-30
NL930058I2 (nl) 1994-02-16
IE41328L (en) 1975-09-26
ZA751391B (en) 1976-10-27
FI63747C (fi) 1983-08-10
CA1040197A (en) 1978-10-10
YU39735B (en) 1985-04-30
ATA227375A (de) 1979-01-15
IE41328B1 (en) 1979-12-05
JPS5855142B2 (ja) 1983-12-08
FR2274289B1 (es) 1979-06-29
DK128075A (es) 1975-09-27
SE7503431L (es) 1975-09-27
PH16276A (en) 1983-08-26
AT351684B (de) 1979-08-10
GB1492426A (en) 1977-11-16
DE2513212A1 (de) 1975-10-09
NO751039L (es) 1975-09-29
NL7503553A (nl) 1975-09-30
DE2513212C2 (de) 1986-03-27
FR2274289A1 (fr) 1976-01-09
HU174973B (hu) 1980-04-28
SE420199B (sv) 1981-09-21
YU73575A (en) 1982-02-28

Similar Documents

Publication Publication Date Title
AR207355A1 (es) Un procedimiento para la preparacion de derivados del acido 7-(-(4-hidroxi-4-alquil-1-alquenil)ciclopentano)-1-heptanoico
AR206627A1 (es) Procedimiento para la preparacion de acido calvulanico
MX5097E (es) Procedimiento para preparar derivados del acido tiazolilacetico
AR193131A1 (es) Un procedimiento para la obtencion de derivados de acido fenoxialquilcarboxilico
AR208111A1 (es) Procedimiento para la preparacion del acido 7-d-(-)-alpha-amino-alpha-(p-hidroxifenilacetamido)cefalosporanico
AR197100A1 (es) Procedimeinto para la fabricacion de un derivado de acido prostanoico
IT1034782B (it) Procedimento per la preparazione di acido metaacrilico
AR205387A1 (es) Un procedimiento para preparar derivados del acido 3-estilbenalcanoico
AR209441A1 (es) Procedimiento para la preparacion de acido 6-d-(-)-alpha-amino-alpha-(acetoxifenilacetamido) penicilanico
AR218221A1 (es) Procedimiento para preparar 5-glutamida del acido 2-aminoetansulfonico
AR203228A1 (es) Procedimiento para preparar derivados de acidos naftil-carbonolamino-alquil fenoxialquilcarboxilicos
AR223803A1 (es) Un procedimiento para la preparacion de derivados del acido picolinico
AR203883A1 (es) Procedimiento para la preparacion de acido 4-ciclopropilmetilenoxi-3-clorofenilacetico
AR208283A1 (es) Un procedimiento para la preparacion de derivados de acido 2-alquil-2-o 3-fefem-4-carboxilico
AR199362A1 (es) Procedimiento para la preparacion de acido 3-cetoglutarico
AR214161A1 (es) Un procedimiento para la preparacion de acido 6-beta-acilamido-1-oxadestiapenicilanicos
AR194412A1 (es) Un procedimiento para la preparacion de derivados de acido alpha-oxi-carboxilico tricilicos
AR201607A1 (es) Procedimiento para la preparacion de acido p-isobutil-hidratropico
AR218217A1 (es) Proceso para la preparacion de acido 3,6-dicloropicolinico
AR207991A1 (es) Procedimiento para la preparacion de esteres del acido 5-n-butil-piridin-2-carboxilicos
AR205012A1 (es) Procedimiento para preparar acido 1h-tetrazol-1-acetico
AR206020A1 (es) Procedimiento para la preparacion de compuestos de 1-t-alquil-3-(3-oxo-ciclohexen-1-il) ureas
AR200312A1 (es) Un procedimiento para la preparacion de derivados del acido prostinoico
AR210835A1 (es) Un procedimiento para la preparacion de dervados de acido anhidroretinoico
AR207879A1 (es) Procedimiento para la preparacion de acido 6-d-(-)-alpha-amino-alpha-(p-hidroxifenilacetamido)penicilanico